Research Site — Philadelphia, Pennsylvania

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

1,185

Registered studies

383

Active

186

Recruiting now

653

Completed

139

Stopped or withdrawn

Most-studied conditions

Human Immunodeficiency Virus Type 1 (HIV-1) Infection · Developmental and Epileptic Encephalopathy 1 · Von Hippel-Lindau Disease · PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or…

Recently updated registry entries

NCT03459846 — A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible… (Active Not Recruiting)
NCT04589845 — Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… (Active Not Recruiting)
NCT06935357 — A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.